This course discusses a study that demonstrated the feasibility of applying the droplet digital PCR platform in minimal residual disease monitoring, allowing clinicians to make prompt decisions for early signs of relapsing leukemia.

This course discusses the programs that decrease point-of-sale medication costs and help remind patients to take medications on time to improve patient adherence and leave the total cost of care unchanged.

This course discusses the proportions of patients with guidance-based “red flag” indications of suboptimal disease control.

This course discusses how social vulnerability impacts the burden of hospitalizations for respiratory syncytial virus.

This course discusses the cause of central line-associated bloodstream infections (CLABSIs) and prevention as a primary concern in maintaining a high standard of hospital care.

This course discusses an evidence-based best practice guidance for assessing and managing patients with psoriatic arthritis.